Key Takeaways
- • PESP released a comprehensive report on private equity dominance in the $30 billion ambulatory surgical center (ASC) market, documenting how leveraged buyouts, joint ventures, and stealth roll-ups are reshaping outpatient care delivery and raising regulatory concerns.
- • The report, authored by PESP researcher Michael Fenne, calls for stronger disclosure requirements and enhanced antitrust oversight to monitor private equity's expanding footprint in ASCs, warning that without reform, cost inflation and reduced community choice are likely outcomes.
- • California enacted two bills in October 2025—SB 351 and AB (designation incomplete in source)—targeting private equity oversight in healthcare, specifically addressing management service organizations (MSOs) and dental service organizations (DSOs) used as vehicles for corporate control of medical and dental practices.
- • SB 351 aims to close legal loopholes that have allowed private equity and corporate investors to influence care delivery while circumventing traditional regulatory frameworks, with PESP noting the law strengthens protections for clinical standards and provider autonomy.
- • The legislative action reflects growing state-level momentum to address private equity's role in healthcare consolidation, marking a shift toward more aggressive regulatory scrutiny of corporate healthcare investment structures.
Summary
The Private Equity Stakeholder Project (PESP) released a landmark October 2025 report examining private equity's pervasive influence in ambulatory surgical centers, a $30 billion market segment that has become a focal point for institutional investor activity and regulatory concern. The report, authored by PESP researcher Michael Fenne, documents how private equity firms have deployed leveraged buyouts, joint ventures, and roll-up strategies to establish dominant market positions in outpatient surgery delivery. The analysis raises material questions about cost escalation, provider autonomy, and competitive consolidation—concerns increasingly shared by policymakers and patient advocates.
The PESP report explicitly calls for regulatory intervention through two mechanisms: strengthened disclosure requirements that would increase transparency around private equity ownership structures and financial flows, and enhanced antitrust enforcement to monitor market concentration in the ASC sector. According to PESP's statement, the current regulatory framework permits private equity-backed consolidation to proceed with insufficient oversight, creating a dynamic where "Wall Street dictates the terms of healthcare delivery" while driving up costs and reducing patient choice. The report received coverage in healthcare-focused trade publications Becker's ASC and MedPage Today, indicating broad professional awareness of the policy implications.
In a significant regulatory development, California Governor Gavin Newsom signed two bills into law in October 2025 addressing private equity's role in healthcare: SB 351 and AB (bill number not fully specified in available source material). Both bills target structural mechanisms—management service organizations (MSOs) and dental service organizations (DSOs)—that private equity firms and other corporate investors have historically used to exercise operational control over independent medical and dental practices without triggering traditional corporate practice of medicine prohibitions.
SB 351 specifically aims to close regulatory loopholes by requiring greater oversight of MSO and DSO arrangements, addressing what PESP characterizes as a critical gap in state law. In a statement, Michael Fenne noted that the legislation "takes an important step toward strengthening California's protections against corporate control of medical and dental practices," while emphasizing that enhanced oversight preserves clinical standards, maintains provider autonomy, and ensures regulatory accountability. The California legislation represents the first major state-level legislative response to private equity healthcare consolidation dynamics documented in PESP's research, establishing a potential template for other jurisdictions considering similar reforms.
The PESP report explicitly calls for regulatory intervention through two mechanisms: strengthened disclosure requirements that would increase transparency around private equity ownership structures and financial flows, and enhanced antitrust enforcement to monitor market concentration in the ASC sector. According to PESP's statement, the current regulatory framework permits private equity-backed consolidation to proceed with insufficient oversight, creating a dynamic where "Wall Street dictates the terms of healthcare delivery" while driving up costs and reducing patient choice. The report received coverage in healthcare-focused trade publications Becker's ASC and MedPage Today, indicating broad professional awareness of the policy implications.
In a significant regulatory development, California Governor Gavin Newsom signed two bills into law in October 2025 addressing private equity's role in healthcare: SB 351 and AB (bill number not fully specified in available source material). Both bills target structural mechanisms—management service organizations (MSOs) and dental service organizations (DSOs)—that private equity firms and other corporate investors have historically used to exercise operational control over independent medical and dental practices without triggering traditional corporate practice of medicine prohibitions.
SB 351 specifically aims to close regulatory loopholes by requiring greater oversight of MSO and DSO arrangements, addressing what PESP characterizes as a critical gap in state law. In a statement, Michael Fenne noted that the legislation "takes an important step toward strengthening California's protections against corporate control of medical and dental practices," while emphasizing that enhanced oversight preserves clinical standards, maintains provider autonomy, and ensures regulatory accountability. The California legislation represents the first major state-level legislative response to private equity healthcare consolidation dynamics documented in PESP's research, establishing a potential template for other jurisdictions considering similar reforms.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.